Evidence map›Paper›PMID 28233656›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017

Initial Session Duration and Mortality Among Incident Hemodialysis Patients.

Shailender Swaminathan, Vincent Mor, Rajnish Mehrotra, Amal N Trivedi

Abstract readComparative Study
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Impact of residual kidney function on hemodialysis adequacy and patient survival.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shailender SwaminathanDepartment of Health Services, Policy and Practice, Alpert Medical School of Brown University, Providence, RI; Providence VA Medical Center, Providence, RI. Electronic address: shailender_swaminathan@brown.edu.
Vincent MorDepartment of Health Services, Policy and Practice, Alpert Medical School of Brown University, Providence, RI; Providence VA Medical Center, Providence, RI.
Rajnish MehrotraDepartment of Medicine, Harborview Medical Center, University of Washington, Seattle, WA.
Amal N TrivediDepartment of Health Services, Policy and Practice, Alpert Medical School of Brown University, Providence, RI; Providence VA Medical Center, Providence, RI.

Funding

Treatment of Anemia in End Stage Renal Disease: Effect of Warnings and IncentivesR21DK095485 · NIDDK · BROWN UNIVERSITY · PI SWAMINATHAN, SHAILENDER · 2011 to 2012
$441k
NIDDK NIH HHS R21 DK095485
6 · The paper itself

Abstract

backgroundThe association of dialysis session duration with mortality in patients undergoing maintenance hemodialysis is unclear. We compared mortality rates of patients treated in dialysis facilities that used initial session durations of either ≥ 4 versus 3 hours for all incident patients. STUDY

designRetrospective cohort study. SETTINGS &

participantsPatients with end-stage renal disease beginning maintenance hemodialysis therapy in January 2006 to December 2010 and followed up through December 2012, including 39,172 patients in 852 facilities who initiated treatment for ≥ 4 hours and 47,721 patients in 631 facilities who initiated treatment for 3 hours. PREDICTOR: Initial session duration of ≥ 4 hours versus 3 hours. OUTCOME: 2- and 1-year mortality rates.

resultsTotal numbers of deaths observed within 2 years after initiating dialysis therapy were 8,945 in the ≥ 4-hour group and 15,624 in the 3-hour group. The corresponding numbers of deaths observed within 1 year were 5,492 and 10,372, respectively. The 2-year adjusted HR in the ≥ 4-hour versus 3-hour group was 0.79 (95% CI, 0.73-0.86). The corresponding 1-year adjusted HR was 0.77 (95% CI, 0.70-0.84). Results were robust when analyses were restricted to specific subgroups of patients classified by age, sex, race, and select clinical characteristics. LIMITATIONS: We did not observe hemodialysis duration in sessions subsequent to initiation. We only included patients treated in facilities with uniform session length (at initiation) for all their patients. Furthermore, we lacked information for dialysis dosage and patients' baseline residual kidney function.

conclusionsPatients in facilities routinely initiating hemodialysis therapy for ≥ 4 hours may have substantially lower mortality as compared with patients in facilities initiating for only 3 hours of treatment.

Indexed as

Cohort StudiesFemaleHumansKidney Failure, ChronicMaleMiddle AgedRenal DialysisRetrospective StudiesTime Factorsdeathend-stage renal disease (ESRD)facility-level analysismortality ratequasi-experimental designRenal hemodialysissession length, dialysis duration, dialysis facilitiestreatment time

Identifiers

PMID28233656
PMCPMC5695674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.